Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Sunday, September 28

2:40 PM - 2:50 PM PT

108 - Evaluating Short Course Radiation and ctDNA for Organ Preservation: The Nonoperative Management and Early Response Assessment in Rectal Cancer (NOM-ERA) Trial
Speaker: Kim, Hyun, MD - Washington University School of Medicine, St. Louis, Missouri
2:40 PM - 2:50 PM PT

115 - Stereotactic Radiotherapy in 3 Fractions for Localized Prostate Cancer
Speaker: Sanguineti, Giuseppe, MD, Mr - Regina Elena National Cancer Institute, Rome, Lazio
2:40 PM - 2:50 PM PT

128 - Fatal Pulmonary Hemorrhage in Patients Treated with Hypofractionated RT for Stage II-III NSCLC
Speaker: Cooke, Saskia, MD - Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, Noord-Holl
2:40 PM - 2:50 PM PT

135 - IL-17-Producing Gd T Cells Recruited By Cgas-Sting-Dependent CCL20 in Macrophages Drive Radioresistance
Speaker: Deng, Yue, MD - Cancer Center Union Hospital, Wuhan
2:44 PM - 2:51 PM PT

123 - Transcriptomic Profiling Reveals Predictive Markers of Response to Concurrent Chemoradiotherapy plus Immune Checkpoint Inhibition in Cervical Cancer
Speaker: Cao, Yuan Jie, MD, PhD - Tianjin Medical University Cancer Institute and Hospital, Tian Jin, Tian Jin
2:50 PM - 3:00 PM PT

102 - Effect of Early Integrated Neuropsychological Care in Patients with Brain Metastases: A Phase 2 Randomized Controlled Trial (ATHENA Trial)
Speaker: Perlow, Haley, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH
2:50 PM - 3:00 PM PT

109 - Comparison of Patterns of Locoregional Recurrence in Total Neoadjuvant Therapy vs. Chemoradiotherapy for Locally Advanced Rectal Cancer in the STELLAR Study
Speaker: Shuai, Jiacheng, MD - Peking Union Medical College Hospital, Beijing, Beijing
2:50 PM - 3:00 PM PT

116 - Two-Year Clinical Outcomes Following Ablative Radiotherapy for Unfavorable Prostate Tumors (ABRUPT)
Speaker: Arcangeli, Stefano, MD - University of Milan Bicocca, Milan, Milan
2:50 PM - 3:00 PM PT

129 - Sequential Chemo-Immunotherapy plus Optimized Thoracic Radiotherapy vs. Standard Thoracic Radiotherapy for Elderly and/ or Frail Stage III Non-Small-Cell Lung Cancer: A Randomized Open-Label Controlled Trial of iLCC-3
Speaker: Qi, Wei-Xiang, MD, RT - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai
2:50 PM - 3:00 PM PT

136 - E2F1-Fanconi Anemia Complementation Group I (FANCI) Mediates Oncogenic BRAF-Driven Radiation Resistance in Anaplastic Thyroid Cancer
Speaker: Yang, Linlin, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte, CA
2:51 PM - 2:58 PM PT

124 - Tracking Changes in B Cell Antibodies in Cervical Cancer Patients Treated with Chemoradiation and Immunotherapy on GOG 9929
Speaker: Kim, Sangwoo, MD - University of California, San Diego, La Jolla, CA
2:58 PM - 3:05 PM PT

125 - Hypofractionated Radiotherapy as a Potential Alternative to Conventional Treatment for Cervical Cancer in Resource-Limited Setting: A Prospective Comparative Analysis
Speaker: Mallum, Abba, MD, PhD - Department of Radiotherapy and Oncology, Inkosi Albert Luthuli Central Hospital, Durban